Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by blogon Aug 09, 2010 8:52am
542 Views
Post# 17332755

My rose coloured glasses

My rose coloured glassesMy understanding is the Europeans are much more accepting of new drugs than the Americans, which means there’s still hope for that submission.  Also, we now have three phase three completions with Voclosporin which means a Canadian submission for psoriasis should be coming shortly. With any luck Atrium will continue on with trials, not sure why they haven’t already.  
<< Previous
Bullboard Posts
Next >>